Rapid release testing detects mycoplasma DNA with great sensitivity by using advanced technologies such nucleic acid ...

Due to the poor positive predictive value of nucleic acid amplification tests (NAATs) for gonorrhoea when applied to a low-prevalence setting, current guidelines recommend the use of supplementary ...

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...

Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform ...

Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular ...

The FDA imposed new restrictions on COVID-19 vaccines, limiting access to the updates shots to people who are at risk for ...

Next-generation sequencing enhances a biologics manufacturer's ability to detect and identify unknown or unexpected contaminants.

This year, the GATE Life Sciences 2026 exam will be organised by IIT Guwahati. The official GATE Life Sciences syllabus PDF ...

The Orissa High Court has asked the state government for a response. This concerns a petition about blood testing. The petition requests advanced ID-NAT implementation. It should be in all ...

Co-Diagnostics ( ($CODX) ) has shared an announcement. On September 17, 2025, Co-Diagnostics, Inc. announced a securities purchase agreement with ...

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that ...